https://bsky.app/profile/pharmaphorum.bsky.social
@pharmaphorum.bsky.social on Bluesky
pharmaphorum.com, and its magazine Deep Dive, is a leading online destination for pharmaceutical industry and healthcare news, insight, and debate
pharmaphorumbskysocialbluesky
https://pharmaphorum.com/rd/viva-vivo-next-generation-cell-therapy-fast-approaching
Viva in vivo: The next generation of cell therapy is fast approaching | pharmaphorum
Discover the latest advancements in cell therapy with the next generation of innovative treatments that are revolutionising healthcare. Explore the future of...
the next generation
https://pharmaphorum.com/rd/reducing-drug-shortages-power-ai-pharma-supply-chain-management
Reducing drug shortages: The power of AI in pharma supply chain management | pharmaphorum
AI-driven solutions are revolutionising the pharmaceutical supply chain management process, particularly in reducing drug shortages. Learn more about the power...
the power of ai
https://pharmaphorum.com/oncology/12-questions-rick-coope
12 Questions with Rick Coope | pharmaphorum
Dive into this exclusive interview with Rick Coope and discover his answers to 12 intriguing questions. Don't miss out!
questionsrickpharmaphorum
https://pharmaphorum.com/news/first-us-hospital-recruits-ibm-watson-oncology
First US hospital recruits IBM Watson for Oncology | pharmaphorum
Watson for Oncology will help doctors at the Jupiter Medical Center create better-informed cancer treatment decisions.
ibm watsonfor oncologyfirstushospital
https://pharmaphorum.com/oncology/news
Oncology News | pharmaphorum
Check here for the latest news about cell and gene therapy, immunotherapeutics, and traditional small molecule approaches to cancer treatment. Stay informed of...
oncology newspharmaphorum
https://pharmaphorum.com/news/cidara-and-mundipharma-prep-filings-for-antifungal-rezafungin
Cidara and Mundipharma prep filings for antifungal rezafungin | pharmaphorum
Mundipharma and Cidara Therapeutics have reported the results of a phase 3 trial of their new once-weekly antifungal rezafungin, setting up regulatory filings...
prepfilingsantifungalpharmaphorum
https://pharmaphorum.com/digital/dtx-east
DTx East | pharmaphorum
dtxeastpharmaphorum
https://pharmaphorum.com/news/roches-parkinsons-hope-fails-second-clinical-trial
Roche's Parkinson's hope fails second clinical trial | pharmaphorum
Roche and Prothena's alpha-synuclein-targeting prasinezumab for Parkinson's fails again, leaving them sifting through the data for efficacy signals.
clinical trialrocheparkinsonhopefails
https://pharmaphorum.com/tag/rubraca
Rubraca | pharmaphorum
pharmaphorum
https://pharmaphorum.com/deep-dive/spatialomics-and-ai-new-age-personalised-clinical-medicine
Spatialomics and AI: A new age for personalised clinical medicine | pharmaphorum
Spatialomics and AI are driving a new era of personalised medicine, moving beyond population-based risk models to deliver individualised insights that guide...
and ainew ageclinical medicine
https://pharmaphorum.com/tag/data-review
data review | pharmaphorum
data reviewpharmaphorum
https://pharmaphorum.com/rd/changing-faces-board-directors-and-advisory-boards-february-2026
Changing Faces: Board of Directors and Advisory Boards, February 2026 | pharmaphorum
Boardrooms and advisory panels across pharma, biotech, medtech, and digital health were busy last month.
board of directorschanging facesadvisory boards
https://pharmaphorum.com/tag/karxt
KarXT | pharmaphorum
pharmaphorum
https://pharmaphorum.com/patients/live-from-frontiers-health-2022
Live from Frontiers Health 2022 - the pharmaphorum podcast | pharmaphorum
In this special, live edition of the pharmaphorum podcast, recorded at the conclusion of Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock and...
live fromfrontiers healthpharmaphorumpodcast
https://pharmaphorum.com/tag/kol-mapping
KOL mapping | pharmaphorum
kol mappingpharmaphorum
https://pharmaphorum.com/tag/pre-emptive-medicine
pre-emptive medicine | pharmaphorum
|pre-emptive medicine
premedicinepharmaphorum
https://pharmaphorum.com/spotlight/frontiers-health-2025
Frontiers Health 2025 | pharmaphorum
Welcome to our Spotlight on Frontiers Health 2025. As the conference marks its 10th year accelerating global health innovation, pharmaphorum – again proud...
frontiers healthpharmaphorum
https://pharmaphorum.com/news/despite-trial-miss-sarepta-plans-new-filing-dmd-therapy
Despite trial miss, Sarepta plans new filing for DMD therapy | pharmaphorum
plans newfor dmddespitetrialmiss
https://pharmaphorum.com/news/pfizer-confirms-generic-medicines-merger-with-mylan
Pfizer confirms generic medicines merger with Mylan | pharmaphorum
generic medicinespfizerconfirmsmergermylan
https://pharmaphorum.com/oncology/reinvigorating-cancer-moonshot-empowered-patients
Reinvigorating the Cancer Moonshot with empowered patients | pharmaphorum
cancer moonshotempowered patientspharmaphorum
https://pharmaphorum.com/tag/sumira-riaz
Sumira Riaz | pharmaphorum
riazpharmaphorum
https://pharmaphorum.com/news/study-backs-closed-loops-drugdigital-blood-pressure-plan
Study backs Closed Loop's drug+digital blood pressure plan | pharmaphorum
Closed Loop Medicine's smartphone app for blood pressure monitoring has shown proof-of-concept in the Cure-19 study.
digital blood pressureclosed loopstudybacks
https://pharmaphorum.com/tag/immunotherapy
immunotherapy | pharmaphorum
immunotherapypharmaphorum
https://pharmaphorum.com/news/bayer-pulls-atrial-fibrillation-study-asundexian
Bayer pulls atrial fibrillation study for asundexian | pharmaphorum
atrial fibrillationbayerpullsstudypharmaphorum
https://pharmaphorum.com/digital/fh25-ten-years-forefront-health-innovation-kristin-milburn
FH25: Ten years at the forefront of health innovation, with Kristin Milburn | pharmaphorum
This November marks a major milestone for health innovation as Frontiers Health celebrates its 10th anniversary. To mark the occasion, pharmaphorum is proud to...
https://pharmaphorum.com/r-d/views-analysis-r-d/5-ways-to-carry-out-a-patient-centric-clinical-trial
5 ways to carry out a patient-centric clinical trial | pharmaphorum
We look at five ways the industry is embracing patient centric clinical trials in a bid to secure the future of their study programmes and develop drugs that...
ways tocarry outclinical trial
https://pharmaphorum.com/tag/giredestrant
Giredestrant | pharmaphorum
pharmaphorum
https://pharmaphorum.com/spotlight/jp-morgan
JP Morgan | pharmaphorum
Each year at the JP Morgan Healthcare Conference, life sciences leaders congregate in San Francisco’s Union Square to network, make deals, and give updates on...
jp morganpharmaphorum
https://pharmaphorum.com/tag/richard-pazdur
Richard Pazdur | pharmaphorum
richardpharmaphorum
https://pharmaphorum.com/tag/intellectual-property
Intellectual property | pharmaphorum
|Intellectual property
intellectual propertypharmaphorum
https://pharmaphorum.com/digital/fh23-multimodal-generative-ai-and-robotics-drug-discovery-and-ageing-research
FH23: Multimodal generative AI and robotics for drug discovery and ageing research | pharmaphorum
Frontiers Health returns on Wednesday 8th November, for a three-day meeting of minds in the Italian capital of Rome.
multimodal generative ai
https://pharmaphorum.com/tag/us-election
US Election | pharmaphorum
us electionpharmaphorum
https://pharmaphorum.com/tag/inflation-reduction-act
Inflation Reduction Act | pharmaphorum
|Inflation Reduction Act
inflation reduction actpharmaphorum
https://pharmaphorum.com/tag/state-union
State of the Union | pharmaphorum
state of the unionpharmaphorum
https://pharmaphorum.com/tag/asco-2020
ASCO 2020 | pharmaphorum
ascopharmaphorum
https://pharmaphorum.com/news/chmp-decision-levels-playing-field-gsks-rsv-jab
CHMP decision levels the playing field for GSK's RSV jab | pharmaphorum
GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.
the playing field
https://pharmaphorum.com/tag/mash
MASH | pharmaphorum
mashpharmaphorum
https://pharmaphorum.com/tag/digital-innovation
digital innovation | pharmaphorum
digital innovationpharmaphorum
https://pharmaphorum.com/tag/ontology
ontology | pharmaphorum
ontologypharmaphorum
https://pharmaphorum.com/news/daiichi-exits-otc-155bn-unit-sale-suntory
Daiichi exits OTC, with $1.55bn unit sale to Suntory | pharmaphorum
Daiichi Sankyo has agreed to sell its consumer health unit to food and beverage giant Suntory, following a well-trodden path for big pharma companies.
daiichiexitsotc
https://pharmaphorum.com/news/ibm-watson-atrius-seek-better-shared-decision-making
IBM Watson and Atrius to encourage patient-doctor dialogue | pharmaphorum
The new partnership will help better inform care shared care and treatment decisions made between doctors and patients.
ibm watsonencouragepatientdoctordialogue
https://pharmaphorum.com/market-access/reuters-pharma-europe-2024
Reuters Pharma Europe 2024 | pharmaphorum
Stay updated on the latest trends and developments in the pharmaceutical industry with Reuters Pharma Europe 2024. Get insights, analysis, and news related to...
reuterspharmaeurope
https://pharmaphorum.com/news/abpi-slams-uk-government-consultation-drug-levy
ABPI slams UK government consultation on drug levy | pharmaphorum
uk governmentabpislamsconsultationdrug
https://pharmaphorum.com/tag/annie-rankin
Annie Rankin | pharmaphorum
annierankinpharmaphorum
https://pharmaphorum.com/news/fda-okays-viivs-apretude-as-first-injectable-for-hiv-prep
FDA okays ViiV's Apretude as first injectable for HIV PrEP | pharmaphorum
GlaxoSmithKline' majority-owned HIV unit ViiV has scored a key FDA approval, getting approval for its long-acting drug cabotegravir as the first injectable for...
https://pharmaphorum.com/deep-dive/equity-and-sustainability
Equity and Sustainability | pharmaphorum
equity and sustainabilitypharmaphorum
https://pharmaphorum.com/news/gilead-kite-acquisition
Gilead completes $11.9bn Kite acquisition | pharmaphorum
Gilead has completed its $11.9 billion acquisition of Kite Pharma, as it switches focus from hepatitis C to cancer and CAR-T therapies.
gileadcompleteskiteacquisitionpharmaphorum
https://pharmaphorum.com/tag/hcp-engagement
HCP engagement | pharmaphorum
hcp engagementpharmaphorum
https://pharmaphorum.com/tag/hca
HCA | pharmaphorum
hcapharmaphorum
https://pharmaphorum.com/tag/cognition
cognition | pharmaphorum
cognitionpharmaphorum
https://pharmaphorum.com/tag/ferring-pharmaceuticals
Ferring Pharmaceuticals | pharmaphorum
|Ferring Pharmaceuticals
ferring pharmaceuticalspharmaphorum
https://pharmaphorum.com/tag/streaming-data
streaming data | pharmaphorum
streaming datapharmaphorum
https://pharmaphorum.com/news/rumour-partly-confirmed-abbvie-acquires-gilgamesh-drug
Rumour partly confirmed as AbbVie acquires Gilgamesh drug | pharmaphorum
Reports of AbbVie's interest in Gilgamesh Pharma were true, as the companies have agreed a $1.2bn acquisition deal for a psychedelic depression drug.
rumourpartlyconfirmedabbvieacquires
https://pharmaphorum.com/spotlight/c-suite-innovators-playbook
C-Suite Innovators’ Playbook | pharmaphorum
c suiteplaybookpharmaphorum
https://pharmaphorum.com/news/biogen-swoops-apellis-56bn-offer
Biogen swoops on Apellis with $5.6bn offer | pharmaphorum
biogenofferpharmaphorum
https://pharmaphorum.com/sales-marketing/deep-dive-commercialisation-2024
Deep Dive: Commercialisation 2024 | pharmaphorum
Deep Dive: Commercialisation 2024 explores the market trends, advancements in GLP-1 therapy, EVERSANA strategies, and a Netflix style impact on the...
deep divecommercialisationpharmaphorum
https://pharmaphorum.com/news/spains-sanifit-chasing-calcium-disorder-blockbuster
Spain's Sanifit chasing calcium disorder blockbuster | pharmaphorum
Spanish biotech Sanifit could have a potential multi-billion dollar treatment in two kidney failure indications.
spainchasingcalciumdisorderblockbuster
https://pharmaphorum.com/terms-conditions
Terms and Conditions | pharmaphorum Guidelines
Read and understand the terms and conditions governing your use of pharmaphorum and our commitment to you.
terms and conditionspharmaphorumguidelines
https://pharmaphorum.com/tag/checkpoint-therapeutics
Checkpoint Therapeutics | pharmaphorum
|Checkpoint Therapeutics
checkpointtherapeuticspharmaphorum
https://pharmaphorum.com/tag/diversity-and-inclusion
diversity and inclusion | pharmaphorum
|diversity and inclusion
diversity and inclusionpharmaphorum
https://pharmaphorum.com/rd/drug-repositioning-bring-forgotten-assets-shelves-patients
Drug repositioning to bring forgotten assets from shelves to patients | pharmaphorum
Learn about drug repositioning, a strategy that involves finding new uses for existing drugs. Discover how this approach brings forgotten assets from shelves...
drug repositioningbringforgottenassetsshelves
https://pharmaphorum.com/digital/remove-friction-unlock-true-potential-ai-precision-intelligence
Remove the friction to unlock the true potential of AI: Precision Intelligence | pharmaphorum
Elevate your AI strategy and remove friction to achieve precision intelligence. Unlock new possibilities for your business with cutting-edge solutions.
true potential
https://pharmaphorum.com/tag/country-focus
country focus | pharmaphorum
country focuspharmaphorum
https://pharmaphorum.com/tag/carolyn-sousa
Carolyn Sousa | pharmaphorum
carolynsousapharmaphorum
https://pharmaphorum.com/news/merck-joins-trump-mfn-gang-ivf-deal
Merck joins the Trump MFN gang with IVF deal | pharmaphorum
Merck KGaA has become the third drugmaker to reach a deal with the Trump administration to cut medicine costs, offering discounts on fertility drugs.
merckjoinstrumpmfngang
https://pharmaphorum.com/tag/corcept-therapeutics
Corcept Therapeutics | pharmaphorum
|Corcept Therapeutics
therapeuticspharmaphorum
https://pharmaphorum.com/news/sanofi-q1-growth-driven-by-genzyme
Sanofi Q1 growth driven by Genzyme | pharmaphorum
Genzyme continued to drive growth for Sanofi in the first quarter, but diabetes drugs are still struggling
sanofigrowthdrivenpharmaphorum
https://pharmaphorum.com/tag/nmpa-approval
NMPA approval | pharmaphorum
nmpaapprovalpharmaphorum
https://pharmaphorum.com/tag/phytome-life-sciences
Phytome Life Sciences | pharmaphorum
|Phytome Life Sciences
life sciencespharmaphorum
https://pharmaphorum.com/tag/tuberous-sclerosis-complex
Tuberous Sclerosis Complex | pharmaphorum
|Tuberous Sclerosis Complex
tuberous sclerosis complexpharmaphorum
https://pharmaphorum.com/views-and-analysis/blockchain-power-cancer-care
The power of blockchain in cancer care transformation | pharmaphorum
Now scientists are exploring how to harness blockchain power to transform the lives of cancer patients and their families and carers.
the power ofcancer careblockchaintransformationpharmaphorum
https://pharmaphorum.com/tag/esmo-2025
ESMO 2025 | pharmaphorum
esmopharmaphorum
https://pharmaphorum.com/tag/life-sciences-real-estate
life sciences real estate | pharmaphorum
|life sciences real estate
life sciences real estatepharmaphorum
https://pharmaphorum.com/tag/islatravir
islatravir | pharmaphorum
pharmaphorum
https://pharmaphorum.com/news/artificial-pancreas-will-be-piloted-in-1000-diabetics-says-nhs-ceo
Artificial pancreas will be piloted in 1,000 diabetics, says NHS CEO | pharmaphorum
NHS England will provide artificial pancreas devices to 1,000 type 1 diabetes patients as part of a pilot study of the technology, according to chief executive...
https://pharmaphorum.com/news/most-patients-wont-see-benefit-alzheimers-drugs
Most patients "won't see benefit" with Alzheimer's drugs | pharmaphorum
A review of clinical data on amyloid-targeting Alzheimer's therapies has found absent or trivial efficacy, but is facing pushback from some experts.
patientssee
https://pharmaphorum.com/tag/zynyz
Zynyz | pharmaphorum
pharmaphorum
https://pharmaphorum.com/rd/video
R&D Videos | pharmaphorum
In pharmaphorum's library of video content, catch interviews with pharma researchers about their latest work as well as their approach to innovation.
r dvideospharmaphorum
https://pharmaphorum.com/partner-content/lyophilisation-strategies-for-freeze-drying-optimisation
Lyophilisation Strategies for Freeze Drying Optimisation | pharmaphorum
Latest Updates in Freeze Drying Technology
freeze dryinglyophilisationstrategiesoptimisationpharmaphorum